Vitros XT7600 reagents
Ended Awarded Last action
- Contract number
- W81K0225FA063
- Awardee
-
Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch UEI JNSJRDQQH2J6
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $29,012
Award facts
- Contract value 100% obligated
- $29,012.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$9,442 | |
| Other Administrative Action | $0 | |
| Original award | $38,454 |
About this award
The Defense Health Agency awarded a $29,012 firm fixed price delivery order to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch for VITROS XT7600 reagents to support the 51st Medical Group at Osan Air Force Base in South Korea. The delivery order, issued on May 30, 2025, is scheduled for completion by September 30, 2025, with performance taking place at the South Korea location. This award does not utilize a set-aside designation and represents a continuation of the vendor's ongoing supply of diagnostic reagents to U.S. military medical facilities in the Asia-Pacific region.
This delivery order likely falls under one of the vendor's existing Indefinite Delivery Vehicles, specifically the Defense Health Agency's $1.25 million Indefinite Delivery Contract for VITROS XT7600 reagents. Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch has established itself as a reliable supplier of advanced diagnostic equipment and reagents to Department of Defense medical facilities, with contract awards ranging from $10,000 to $2.66 million. The company's provision of VITROS diagnostic reagents supports critical medical readiness and diagnostic capabilities for U.S. military healthcare operations at installations including Camp Humphreys and Osan Air Base.
Quick answers
Who was awarded contract W81K0225FA063?
W81K0225FA063 was awarded to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch by Medical Command (Department of the Army) on May 30, 2025.
How much is contract W81K0225FA063 worth?
The government has obligated $29,012 on W81K0225FA063.
Which agency awarded contract W81K0225FA063?
Medical Command (Department of the Army) awarded W81K0225FA063, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0225FA063 an order under another contract?
Yes. W81K0225FA063 is a delivery order under W81K0225DA003, an indefinite delivery contract.
Was contract W81K0225FA063 competed?
The extent of competition for W81K0225FA063 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award